Skip to main content

Want a detailed portfolio tracker?

ReShape Lifesciences (HIND) P/E (2025 - 2026)

ReShape Lifesciences (HIND) P/E from Jun 30, 2025 to Jul 21, 2026. The TTM ReShape Lifesciences (HIND) P/E is -0.54. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ReShape Lifesciences (HIND)

YearP/EChange
2026-0.54-38.79%
2025-0.89N/A

Comparison ReShape Lifesciences (HIND) P/E with competitors

ReShape Lifesciences (HIND) P/E is -0.54.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.31%
NBYStablecoin Development Corp0.00-100.79%
ENLVEnlivex Ltd0.07-113.76%
FGENFibroGen Inc0.24-144.15%
CHRSCoherus Biosciences Inc0.85-256.05%
FBIOFortress Biotech Inc0.95-274.53%
ORMPOramed Pharmaceuticals Inc1.50-376.42%
AGENAgenus Inc3.01-653.49%
INVAInnoviva Inc3.15-680.04%
VXRTVaxart Inc3.55-752.82%
CRMDCorMedix Inc3.63-767.29%
CVACCureVac N.V.4.45-917.58%
GLPGGalapagos NV4.86-993.58%
SRPTSarepta Therapeutics Inc4.88-997.84%
ABEOAbeona Therapeutics Inc5.39-1090.79%
ABUSArbutus Biopharma Corp5.60-1129.07%
ZVRAZevra Therapeutics Inc5.89-1182.70%
SPROSpero Therapeutics Inc6.23-1245.45%
CGENCompugen Ltd6.31-1261.17%
RIGLRigel Pharmaceuticals6.87-1363.81%
SLXNSilexion Therapeutics Corp7.30-1441.79%
OMEROmeros Corporation9.26-1802.74%
AUPHAurinia Pharmaceuticals Inc9.58-1862.73%
PLXProtalix BioTherapeutics Inc10.89-2102.92%
ACADAcadia Pharmaceuticals Inc11.73-2256.95%
TBPHTheravance Biopharma Inc12.26-2355.09%
ADMAAdma Biologics Inc12.42-2383.78%
HRMYHarmony Biosciences Holdings Inc13.82-2641.62%
SABSSAB Biotherapeutics Inc14.14-2699.74%
NAGENiagen Bioscience Inc14.82-2825.15%
INCYIncyte Corp15.82-3009.87%
REGNRegeneron Pharmaceuticals Inc15.86-3016.14%
PBYIPuma Biotechnology Inc17.32-3284.47%
CPRXCatalyst Pharmaceuticals Inc17.44-3307.20%
EXELExelixis Inc17.54-3325.35%
TGTXTG Therapeutics Inc18.97-3587.98%
MDXGMimedx Group Inc20.55-3879.74%
XOMAXOMA Royalty Corp22.87-4306.92%
ARGXArgen X SE24.30-4568.68%
CTMXCytomX Therapeutics Inc24.82-4664.88%
XOMAOXOMA Royalty Corp25.34-4761.20%
HALOHalozyme Therapeutics Inc25.62-4812.49%
XOMAPXOMA Royalty Corp25.67-4821.03%
VRTXVertex Pharmaceuticals Inc27.99-5248.55%
RPRXRoyalty Pharma plc - Class A28.69-5375.97%
SLNOSoleno Therapeutics Inc29.02-5436.25%
ASNDAscendis Pharma A/S30.09-5633.08%
LGNDLigand Pharmaceuticals Inc - Class B37.91-7072.45%
APLSApellis Pharmaceuticals Inc39.02-7276.45%
BMRNBiomarin Pharmaceutical Inc42.21-7863.24%
KRYSKrystal Biotech Inc45.34-8439.18%
ONCBeiGene Ltd69.54-12889.29%
PHARPharming Group N.V.75.03-13898.07%
TECHBio-Techne Corp101.96-18851.32%
VCELVericel Corp109.92-20315.80%
ALNYAlnylam Pharmaceuticals Inc117.96-21795.14%
GMABGenmab140.29-25901.09%
TLXTelix Pharmaceuticals Ltd162.15-29921.78%
CORTCorcept Therapeutics Inc212.86-39246.96%